Medical Research Council Adult Acute Lymphoblastic Leukaemia Trial UKALL XA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN35362654

Enrollment

618

Registered

2002-08-19

Start date

1985-01-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukaemia (acute) Cancer Lymphoid leukaemia

Interventions

All patients receive induction, central nervous system (CNS) prophylaxis and maintenance. Patients are randomised to one of four treatment arms: 1. Arm A: Early intensification therapy to be given imm

Eligibility

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed ALL 2. Aged >25 years

Exclusion criteria

Exclusion criteria: Not provided at time of registration.

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration.	—

Secondary

Measure	Time frame
Not provided at time of registration.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026